The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.
Open accessAbstract
It has been convincingly demonstrated that genotoxic stresses cause the accumulation of the tumor suppressor gene p53. One important consequence of increased p53 protein levels in response to DNA damage is the activation of a G1-phase cell cycle checkpoint. It has also been shown that G1-phase cell cycle checkpoints are activated in response to other stresses, such as lack of oxygen. Here we show that hypoxia and heat, agents that induce cellular stress primarily by inhibiting oxygen-dependent metabolism and denaturing proteins, respectively, also cause an increase in p53 protein levels. The p53 protein induced by heat is localized in the cytoplasm and forms a complex with the heat shock protein hsc70. The increase in nuclear p53 protein levels and DNA-binding activity and the induction of reporter gene constructs containing p53 binding sites following hypoxia occur in cells that are wild type for p53 but not in cells that possess mutant p53. However, unlike ionizing radiation, the accumulation of cells in G1 phase by hypoxia is not strictly dependent on wild-type p53 function. In addition, cells expressing the human papillomavirus E6 gene, which show increased degradation of p53 by ubiquitination and fail to accumulate p53 in response to DNA-damaging agents, do increase their p53 levels following heat and hypoxia. These results suggest that hypoxia is an example of a "nongenotoxic" stress which induces p53 activity by a different pathway than DNA-damaging agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Self-citationp53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,078
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,862
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., & Levine, A. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.531 · Cited by 1,144
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Identification of p53 as a Sequence-Specific DNA-Binding Protein
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085
Oncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix
Höckel, M., Knoop, C., Schlenger, K., Vorndran, B., Bauβnann, E., Mitze, M., Knapstein, P. G., & Vaupel, P. (1993) · Radiotherapy and Oncology · doi:10.1016/0167-8140(93)90025-4 · Cited by 809
Gatenby, R. A., Kessler, H. B., Rosenblum, J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H., & Broder, G. J. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90002-8 · Cited by 798
p53 functions as a cell cycle control protein in osteosarcomas.
Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., & Vogelstein, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 772
A transcriptionally active DNA-binding site for human p53 protein complexes.
Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., & Shay, J. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2866 · Cited by 732
Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents.
Fornace, A. J., Nebert, D. W., Hollander, M. C., Luethy, J. D., Papathanasiou, M., Fargnoli, J., & Holbrook, N. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.10.4196 · Cited by 705
Self-citationDNA damage-inducible transcripts in mammalian cells.
Fornace, A. J., Alamo, I., & Hollander, M. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8800 · Cited by 624
Self-citationVariation in Sensitivity to Heat Shock during the Cell-cycle of Chinese Hamster Cells in Vitro
Westra, A., & Dewey, W. C. (1971) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553007114550601 · Cited by 613
Mechanisms of Tumor Progression
Conti, C. J. (2010) · Comprehensive Toxicology · doi:10.1016/b978-0-08-046884-6.01417-2 · Cited by 608
Walker, G. C. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.002233 · Cited by 571
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., & Cho, K. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3988 · Cited by 526
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.
Oren, M., Maltzman, W., & Levine, A. J. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.2.101 · Cited by 489
Koong, A. C., Chen, E. Y., & Giaccia, A. J. (1994) · PubMed · Cited by 445
Self-citationInduction of cellular p53 activity by DNA-damaging agents and growth arrest.
Zhan, Q., Carrier, F., & Fornace, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4242 · Cited by 441
Self-citationMechanisms of tumor progression.
Nowell, P. C. (1986) · PubMed · Cited by 440
Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
Isaacs, W. B., Carter, B. S., & Ewing, C. M. (1991) · PubMed · Cited by 433
Gillette, E. L., & Hahn, G. M. (1983) · Radiation Research · doi:10.2307/3576270 · Cited by 418
Tumor hypoxia: its impact on cancer therapy
Moulder, J. E., & Rockwell, S. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00055376 · Cited by 414
Wolf, D., & Rotter, V (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.790 · Cited by 410
Specific interaction between the p53 cellular tumour antigen and major heat shock proteins
Pinhasi-Kimhi, O., Michalovitz, D., Ben-Zeev, A., & Oren, M. (1986) · Nature · doi:10.1038/320182a0 · Cited by 329
(1993) · PubMed · Cited by 323
Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53.
Reich, N. C., Oren, M., & Levine, A. J. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.12.2143 · Cited by 312
O'Connor, P. M., Jackman, J., Jondle, D., Bhatia, K. G., MAGRATH, I. T., & Kohn, K. W. (1993) · PubMed · Cited by 306
Regulation of protein synthesis in HeLa cells: Translation at elevated temperatures
McCormick, W., & Penman, S. (1969) · Journal of Molecular Biology · doi:10.1016/0022-2836(69)90320-9 · Cited by 296
Rice, G. C., Hoy, C., & Schimke, R. T. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5978 · Cited by 249
The mdm-2 gene is induced in response to UV light in a p53-dependent manner.
Perry, M. E., Piette, J., Zawadzki, J. A., Harvey, D., & Levine, A. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11623 · Cited by 247
Hinds, P. W., Finlay, C. A., Frey, A. B., & Levine, A. J. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2863 · Cited by 232
Sciandra, J. J., Subjeck, J. R., & Hughes, C. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4843 · Cited by 225
The p53-dependent gamma-ray response of GADD45.
Zhan, Q., Bae, I., Kastan, M. B., & Fornace, A. J. (1994) · PubMed · Cited by 223
Self-citationThe human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle.
Denko, N. C., Giaccia, A. J., Stringer, J. R., & Stambrook, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5124 · Cited by 209
Self-citationTishler, R. B., Calderwood, S. K., Coleman, C. N., & Price, B. D. (1993) · PubMed · Cited by 200
The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses
Levine, A. J. (1990) · Virology · doi:10.1016/0042-6822(90)90505-l · Cited by 192
Price, B. D., & Calderwood, S. K. (1992) · PubMed · Cited by 173
Cannon, J. V., & Lane, D. P. (1991) · Nature · doi:10.1038/349802a0 · Cited by 173
Activation of the heat shock transcription factor by hypoxia in mammalian cells.
Benjamin, I. J., Kröger, B., & Williams, R. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6263 · Cited by 172
Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes
Hubbert, N. L., Sedman, S. A., & Schiller, J. T. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.6237-6241.1992 · Cited by 172
Band, V., Dalal, S. N., Delmolino, L. M., & Androphy, E. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05833.x · Cited by 138
Åmellem, Ø., & Pettersen, E. O. (1991) · Cell Proliferation · doi:10.1111/j.1365-2184.1991.tb01144.x · Cited by 122
Induction characteristics of oxygen regulated proteins
Heacock, C. S., & Sutherland, R. M. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90155-0 · Cited by 115
Pietenpol, J. A., & Vogelstein, B. (1993) · Nature · doi:10.1038/365017a0 · Cited by 96
Regulation of protein metabolism of human cells during and after acute hypoxia.
Pettersen, E. O., Juul, N. O., & Rønning, Ø. W. (1986) · PubMed · Cited by 79
Effect of Transient Hypoxia on Sensitivity to Doxorubicin in Human and Murine Cell Lines
Luk, C. K., Veinot-Drebot, L. M., Tjan, E., & Tannock, I. F. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.8.684 · Cited by 75
The p53 tumor suppressor gene and gene product.
Levine, A. J. (1989) · PubMed · Cited by 57
Cell killing, radiosensitization and cell cycle redistribution induced by chronic hypoxia
Spiro, I. J., Rice, G. C., Durand, R. E., Stickler, R., & Ling, C. (1984) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(84)90332-8 · Cited by 54
Probst, H., Schiffer, H., Gekeler, V., Kienzle‐Pfeilsticker, H., Stropp, U., Stötzer, K.-E., & Frenzel-Stötzer, I. (1988) · PubMed · Cited by 54
Stoler, D. L., Anderson, G. R., Russo, C. A., Spina, A., & Beerman, T. A. (1992) · PubMed · Cited by 49
Srivastava, S. K., Tong, Y. A., Devadas, K., Zou, Z., Chen, Y., Pirollo, K. F., & Chang, E. H. (1992) · Carcinogenesis · doi:10.1093/carcin/13.7.1273 · Cited by 47
Takahashi, K., Sumimoto, H., Suzuki, K., & Ono, T. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940080112 · Cited by 39
Pettersen, E. O., & Lindmo, T. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.271 · Cited by 38
Giaccia, A. J., Auger, E. A., Koong, A. C., Terris, D. J., Minchinton, A. I., Hahn, G. M., & Brown, J. M. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90667-7 · Cited by 32
Self-citationMolecular mechanisms for the induction of chromosomal aberrations in CHO cells heated in S phase
Wong, R. S. L., & Dewey, W. C. (1993) · Environmental and Molecular Mutagenesis · doi:10.1002/em.2850220413 · Cited by 16
Cited by
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Metadata
- Authors
- Graeber, T. G., Peterson, J. F., Tsai, M., Monica, K., Fornace, A. J., & Giaccia, A. J.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1994-09
- Volume
- 14
- Issue
- 9
- Pages
- 6264-6277
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2143778153
- Cited by
- 614
- References
- 72
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.